The seventh edition of this rapid-access reference has been revised and updated to incorporate the extraordinary amount of clinical data that has appeared in the literature over the past five years. A number of new drugs have been added including risperdone, sertraline, paroxetine, venlafaxine, nefazodone, zolpedem, and fluvoxamine.



